Marie‐Blanche Valnet‐Rabier

856 citations
28 papers · 478 indexed · h-index 13
Topics
Pharmacovigilance and Adverse Drug Reactions (10 papers)Drug-Induced Adverse Reactions (8 papers)Pharmaceutical Practices and Patient Outcomes (6 papers)
Partner nations
FranceCanadaLebanon

In The Last Decade

Marie‐Blanche Valnet‐Rabier

26 papers receiving 465 citations

Peers

Marie‐Blanche Valnet‐Rabier
Comparison fields: 5 of 75
  • Molecular Biology 97
  • Pathology and Forensic Medicine 96
  • Pharmacology 86
  • Oncology 83
  • Toxicology 83
Replace Kui Huang with:
Kui Huang United States
Mo Dimbil United States
Mayako Uchida Japan
Sruthi Adimadhyam United States
Vishvas Garg United States
Anne B. Taegtmeyer Switzerland
Amandine Gouverneur France
Josephina G. Kuiper Netherlands
Ayad K. Ali United States
Valentina Ientile Italy
Marie‐Blanche Valnet‐Rabier relative to Kui Huang United States Kui Huang's profile →
Citations per field
00.5×
Kui Huang · 1×
Citations per year

Countries citing papers authored by Marie‐Blanche Valnet‐Rabier

Since Specialization
Citations

This map shows the geographic impact of Marie‐Blanche Valnet‐Rabier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie‐Blanche Valnet‐Rabier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie‐Blanche Valnet‐Rabier more than expected).

Fields of papers citing papers by Marie‐Blanche Valnet‐Rabier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie‐Blanche Valnet‐Rabier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie‐Blanche Valnet‐Rabier. The network helps show where Marie‐Blanche Valnet‐Rabier may publish in the future.

Co-authorship network of co-authors of Marie‐Blanche Valnet‐Rabier

This figure shows the co-authorship network connecting the top 25 collaborators of Marie‐Blanche Valnet‐Rabier. A scholar is included among the top collaborators of Marie‐Blanche Valnet‐Rabier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie‐Blanche Valnet‐Rabier. Marie‐Blanche Valnet‐Rabier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 5
4 4
5 5
6 7
7 15
8 0
9 8
10 17
11 23
12 20
13 7
14 39
15 1
16 4
17 20
18 58
19 58
20 38

About Marie‐Blanche Valnet‐Rabier

Marie‐Blanche Valnet‐Rabier is a scholar working on Toxicology, Geriatrics and Gerontology and Pharmacology, having authored 28 papers that have together received 478 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (10 papers), Drug-Induced Adverse Reactions (8 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). The work is most often cited by research in Toxicology (83 citations), Geriatrics and Gerontology (59 citations) and Family Practice (13 citations). Marie‐Blanche Valnet‐Rabier has collaborated with scholars based in France, Canada and Lebanon. Frequent co-authors include Hélène Théophile, Yannick Arimone, Jean-Paul Dutertre, Dominique Hillaire‐Buys, Claire Guy, Marie Gérardin, Françoise Haramburu, Christiane Mougin, Éric Deconinck and R Angonin. Their work appears in journals such as Blood, Ophthalmology and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026